MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.500
-0.100 (-6.25%)
At close: Nov 14, 2025, 4:00 PM EST
1.511
+0.011 (0.75%)
After-hours: Nov 14, 2025, 7:35 PM EST
MacroGenics Stock Forecast
Stock Price Forecast
The 5 analysts that cover MacroGenics stock have a consensus rating of "Hold" and an average price target of $3.20, which forecasts a 113.33% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $5.00.
Price Target: $3.20 (+113.33%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for MacroGenics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Hold | 7 | 7 | 7 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $2 | Hold | Reiterates | $2 | +33.33% | Nov 3, 2025 |
| Barclays | Barclays | Buy Initiates $3 | Buy | Initiates | $3 | +100.00% | Sep 17, 2025 |
| B. Riley Securities | B. Riley Securities | Hold Maintains $5 → $3 | Hold | Maintains | $5 → $3 | +100.00% | May 20, 2025 |
| Stifel | Stifel | Hold Maintains $6 → $5 | Hold | Maintains | $6 → $5 | +233.33% | May 14, 2025 |
| Barclays | Barclays | Buy Maintains $8 → $3 | Buy | Maintains | $8 → $3 | +100.00% | May 14, 2025 |
Financial Forecast
Revenue This Year
71.43M
from 149.96M
Decreased by -52.37%
Revenue Next Year
45.42M
from 71.43M
Decreased by -36.42%
EPS This Year
-2.03
from -1.07
EPS Next Year
-1.66
from -2.03
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 102.8M | 112.5M | |||
| Avg | 71.4M | 45.4M | |||
| Low | 53.3M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -31.4% | 57.4% | |||
| Avg | -52.4% | -36.4% | |||
| Low | -64.4% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.44 | -0.26 | |
| Avg | -2.03 | -1.66 | |
| Low | -2.65 | -2.84 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.